Consumer Staples › Medicinal Chemicals And Botanical Products
USNA Stock Price Correlated With USANA Health Sciences Financials
External Links ⌄
Income Statement
Cash Flow
Balance Sheet
USNA Income Statement
Enable JavaScript and reload
Revenue, Net:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
USNA Cash Flow
Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:
USNA Balance Sheet
Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:
COMPANY PROFILE
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
COVID- 19
The COVID- 19 pandemic has negatively impacted economies, businesses, sales practices, supply chains, and consumer behavior around the world. While the overall impact of the COVID- 19 pandemic on our business and results of operations has not been material, these factors and other events related to the pandemic have created meaningful disruptions in both the Company's sales and operations for fiscal 2021 and 2020. At this time, the Company is unable to predict the impact that COVID- 19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.
The Company
USANA Health Sciences, Inc. develops and manufactures high quality, science-based nutritional and personal care products that are sold internationally through a direct selling channel. The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: ( 1) Asia Pacific, and ( 2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
( 1) Asia Pacific –
(i) Greater China – Hong Kong, Taiwan, and China. The Company’s business in China is conducted by BabyCare Holdings, Ltd. (“BabyCare”), the Company’s wholly-owned subsidiary.
(ii) Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand and Indonesia.
(iii) North Asia – Japan and South Korea.
( 2) Americas and Europe – United States, Canada, Mexico, Colombia, the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands.
Principles of Consolidation and Basis of Presentation The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year The Company operates on a 52/53 -week year, ending on the Saturday closest to December 31. Fiscal years 2021 and 2019 were 52 -week years. Fiscal year 2020 was a 53 -week year. Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 ( hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 ( hereinafter 2020). Fiscal year 2019 covered the period December 30, 2018 to December 28, 2019 ( hereinafter 2019).
Fair Value Measurements The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
● Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
● Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset
COVID- 19
The COVID- 19 pandemic has negatively impacted economies, businesses, sales practices, supply chains, and consumer behavior around the world. While the overall impact of the COVID- 19 pandemic on our business and results of operations has not been material, these factors and other events related to the pandemic have created meaningful disruptions in both the Company's sales and operations for fiscal 2021 and 2020. At this time, the Company is unable to predict the impact that COVID- 19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.
The Company
USANA Health Sciences, Inc. develops and manufactures high quality, science-based nutritional and personal care products that are sold internationally through a direct selling channel. The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: ( 1) Asia Pacific, and ( 2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
( 1) Asia Pacific –
(i) Greater China – Hong Kong, Taiwan, and China. The Company’s business in China is conducted by BabyCare Holdings, Ltd. (“BabyCare”), the Company’s wholly-owned subsidiary.
(ii) Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand and Indonesia.
(iii) North Asia – Japan and South Korea.
( 2) Americas and Europe – United States, Canada, Mexico, Colombia, the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands.
Principles of Consolidation and Basis of Presentation The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year The Company operates on a 52/53 -week year, ending on the Saturday closest to December 31. Fiscal years 2021 and 2019 were 52 -week years. Fiscal year 2020 was a 53 -week year. Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 ( hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 ( hereinafter 2020). Fiscal year 2019 covered the period December 30, 2018 to December 28, 2019 ( hereinafter 2019).
Fair Value Measurements The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
● Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
● Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset
Free historical financial statements for USANA Health Sciences Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 48 quarters since 2012. Compare with USNA stock chart to see long term trends.
Data imported from USANA Health Sciences Inc. SEC filings. Check original filings before making any investment decision.